The research, carried out through a synergistic collaboration between teams at the University of Liverpool, Japan’s University of Hyogo, and Argentina, harnessed the unparalleled brilliance and ultrafast pulse durations of XFEL beams generated at SACLA, the XFEL facility located in Japan. Unlike traditional synchrotron X-ray sources, XFELs produce femtosecond pulses with intensities that enable the capture of diffraction patterns before radiation damage can compromise molecular integrity. This property has allowed scientists, for the first time, to visualize protein structures with atomic precision free from artifacts induced by X-ray exposure.

Copper nitrite reductase is a metalloenzyme active in denitrification pathways integral to nitrogen cycling. By facilitating the electron-driven and proton-coupled conversion of nitrite into nitric oxide—a gaseous signaling molecule—CuNiR is pivotal in modulating nitrogen flux in ecosystems. Despite its biological prominence, the atomistic details of its catalytic mechanism have remained elusive for decades, largely due to the difficulty of capturing transient intermediates and dynamic protonation states. The current study confronts these challenges head-on by deploying XFEL-based crystallography alongside sophisticated computational refinement algorithms.

Central to their structural investigation is the resolution of a long-standing debate regarding CuNiR’s catalytic sequence—whether it follows a random sequential mechanism or a strictly ordered series of substrate and cofactor interactions. The crystallographic snapshots, captured at different stages of enzymatic turnover, unequivocally demonstrate an ordered mechanism. Data reveal a delicate choreography wherein electron transfer from the copper center, substrate binding, and proton donation occur in a coordinated and temporally gated fashion, thereby elucidating the enzyme’s remarkable efficiency and specificity.

Utilizing the high photon energies exceeding 13 keV, the XFEL pulses—of approximately ten femtoseconds duration—afforded diffraction data that were processed using the SHELXL refinement software. This program, renowned for its precision in small-molecule crystallography, was innovatively adapted for macromolecular data, enabling the researchers to refine electron density maps with unprecedented clarity. The integration of these tools marks a significant methodological leap, showcasing that atomic-level precision in protein structures, once only attainable through small-molecule crystallography, is now within reach via XFEL methods.

The implications of this work extend beyond enzymology, heralding a transformative era in biomolecular imaging where radiation damage-free snapshots can reveal ephemeral states critical to function. By capturing XFEL diffraction images before deleterious chemical transformations ensue, the team ensured that observed structures represent true physiological intermediates rather than post-irradiation artifacts. This fidelity is crucial for mechanistic studies of redox-active enzymes, where subtle changes in oxidation states and ligand geometries dictate biological outcomes.

Dr. Svetlana Antonyuk from the University of Liverpool emphasized the transformative potential of XFELs in structural biology, noting that the use of ultra-short, high-energy X-ray pulses “can be successfully harnessed to provide atomic resolution structures that are free from X-ray induced redox or chemical changes.” This capability is vital for accurately characterizing metalloproteins like CuNiR, where metal centers undergo delicate redox cycling during catalysis. The elimination of radiation-induced alterations paves the way for new insights into the enzymatic function under near-native conditions.

Professor Samar Hasnain highlighted the tribute to Professor George Sheldrick, acknowledging the revolutionary impact of the SHELXL refinement approach on macromolecular crystallography. Their work stands at a confluence of technological innovation and analytical rigor, as it is the first published study to apply the SHELXL method to XFEL-derived atomic resolution protein structures. This pioneering application signals a paradigm shift in how crystallographic data from large biomolecules can be processed, boosting both accuracy and interpretability.

The biological significance of copper nitrite reductase also ties into broader environmental considerations, particularly in understanding nitrogen turnover and its influence on greenhouse gas emissions and soil fertility. Nitric oxide generated by CuNiR functions as a crucial mediator in microbial ecosystems, influencing processes such as nitrification and denitrification that regulate nitrogen availability. Hence, molecular-level insights into CuNiR aid not only fundamental science but also environmental stewardship and potentially biotechnological applications aimed at managing nitrogen fluxes.

The study’s publication in the prestigious journal Nature Communications underscores the scientific community’s recognition of its importance. Through the precise visualization of enzymatic intermediate states, the authors offer a template for future investigations into other complex metalloenzymes and biomolecular machines. The amalgamation of advanced experimental modalities with computational refinement heralds an era where biomolecular dynamics can be dissected with atomic fidelity in real time.

In summary, the groundbreaking work by Antonyuk, Hasnain, Tosha, Yamamoto, and their colleagues exemplifies the frontiers of modern structural biology enabled by XFEL technology. Their atomic-resolution maps of copper nitrite reductase illuminate fundamental biochemical processes that have wide-reaching implications—from enzymatic catalysis to environmental nitrogen cycling. This research not only resolves longstanding mechanistic controversies but also sets a new benchmark for the application of femtosecond X-ray crystallography in the life sciences.

Subject of Research: Structural elucidation of copper nitrite reductase enzyme and its catalytic mechanism using advanced XFEL techniques.

Article Title: Atomic-Resolution Insights into Copper Nitrite Reductase Catalysis via XFEL Crystallography

Web References:
https://www.nature.com/articles/s41467-026-70261-1

References:
Published in Nature Communications.

Keywords

Copper nitrite reductase, XFEL, femtosecond X-rays, atomic resolution, enzyme catalysis, nitrogen cycle, metalloproteins, SHELXL refinement, biochemistry, structural biology.

The study delves into a hitherto poorly understood interplay between gut microbiota and neuronal signaling pathways governing intestinal movement. Researchers have identified that in models of ACh deficiency — which mimic neuronal deficits — a compensatory rise in intestinal ammonia occurs alongside increased urease enzyme activity. This enzyme, produced by specific gut bacteria, catalyzes the hydrolysis of urea into ammonia and carbon dioxide, pointing to a microbial metabolic response finely tuned to host physiological states. Such findings illuminate the complex adaptive nature of the gut microbiome in supporting host functions beyond mere digestion.

Clinical correlations extend these findings from animal models to human health. In patients suffering from constipation, a condition marked by sluggish gut motility, elevated levels of ammonia and heightened urease activity were also documented. This discovery suggests that the microbial ecosystem reacts to impaired neurotransmitter activity by boosting ammonia production, potentially offering an alternative mechanism to stimulate intestinal motility. These insights mark a pivotal step forward in understanding how the microbiome might compensate for neuronal deficits in gastrointestinal disorders.

Further experimental exploration leveraged bacterial isolates from patient stool, particularly focusing on the urease-positive bacterium Lysinibacillus fusiformis. Upon colonization in murine models exhibiting dysmotility, this microbial species was able to restore colonic ACh concentrations effectively. Complementing this, researchers engineered bacteria to express urease, corroborating that enhanced ammonia production by these microbes consequentially elevated ACh levels. These findings open new avenues for microbiota-targeted therapies, emphasizing the therapeutic potential of manipulating microbial nitrogen metabolism to rectify gastrointestinal dysfunctions.

On a molecular level, the research delved into how ammonia influences enteric neurons to modulate ACh secretion. In vitro studies demonstrated that ammonia upregulates the expression of voltage-gated calcium channels on these neurons. This upregulation enhances calcium influx, a critical signal that triggers the release of acetylcholine, thereby facilitating neurogenic stimulation of intestinal smooth muscle. Such a mechanism suggests that microbial ammonia acts as an effector molecule, bridging microbial metabolism and neuronal activity in a precise biochemical dialogue.

Considering the complexity of intestinal motility regulation, these findings provide compelling evidence supporting a model where gut microbiota serve as dynamic partners in maintaining gut homeostasis. The gut microbiome, often viewed simply as a digestive aid, now emerges as an active participant in neurochemical regulation within the enteric nervous system, revealing a sophisticated host-microbe symbiosis. This discovery challenges traditional views and introduces a new paradigm for understanding gastrointestinal health.

The implications of these findings are far-reaching, especially in the context of conditions where neuronal signaling is impaired. The ability of microbial ammonia to compensate for acetylcholine deficiency offers a novel therapeutic target that diverges from conventional treatments focused on direct neuronal modulation or pharmacologic stimulation. Harnessing microbial urease activity might provide less invasive, microbiota-based interventions ideal for managing chronic constipation and other motility disorders that are often resistant to current therapies.

Moreover, this study highlights the intricate interdependencies between diet, microbial metabolism, and host physiology. Nitrogen metabolism by gut bacteria, facilitated in part by dietary urea and proteins, dynamically influences ammonia availability in the gut environment. Understanding how dietary components regulate this axis can lead to precision nutrition strategies aimed at optimizing microbial contributions to neurotransmitter balance and intestinal motility.

Researchers also underscore the potential for engineered probiotics designed to enhance or mimic urease activity selectively. Such microbial therapeutics could be tailored to individuals suffering from hypomotility-related disorders, offering personalized medicine approaches that manipulate the gut microbiota to restore neuronal and muscular function. These interventions could redefine the treatment landscape for patients with functional bowel disorders, emphasizing microbiome modulation as a cornerstone of therapy.

Nonetheless, the study cautions that ammonia, while beneficial in this context, must be carefully regulated due to its toxicity at elevated systemic levels. Future research will need to address how localized effects in the gut lumen versus systemic absorption influence the safety and efficacy of microbiota-based ammonia modulation. Balancing this duality will be paramount as clinical applications move forward.

Additionally, the discovery prompts a reevaluation of existing gut microbial dynamics in health and disease. The presence of urease-positive bacteria within the human gut may have been underestimated in their functional importance, and this study invites renewed exploration into the microbial ecology influencing enteric nervous system function. Such research could identify biomarkers of dysmotility linked to microbial nitrogen metabolism and help stratify patient populations for targeted therapies.

The study’s revelations further emphasize the necessity of interdisciplinary approaches combining microbiology, neurobiology, and gastroenterology to unravel the complexities of gut motility regulation. Such collaboration is critical as the field moves towards integrating microbial ecology with neuronal physiology to develop holistic treatment modalities. This integrative perspective may inspire similar investigations into other neuro-immune-microbial axes within the body.

In closing, the intricate dance between gut microbial ammonia production and colonic acetylcholine secretion profoundly reshapes our understanding of intestinal motility regulation. This groundbreaking research not only identifies a novel molecular mechanism underpinning microbial influence on host neurophysiology but also lays the foundation for innovative microbial-based treatments that could transform the management of intestinal motility disorders. It heralds a promising era where the gut microbiome is harnessed as a reliable ally in maintaining gastrointestinal health and combating chronic disease.

Subject of Research: Gut microbiota, intestinal motility, acetylcholine regulation, ammonia production, and enteric nervous system interactions.

Article Title: Gut microbial ammonia enhances colonic acetylcholine levels to regulate intestinal motility.

Article References:
Chen, H., Wang, Z., Zhao, Y. et al. Gut microbial ammonia enhances colonic acetylcholine levels to regulate intestinal motility. Nat Microbiol (2026). https://doi.org/10.1038/s41564-026-02269-8

Image Credits: AI Generated

DOI: https://doi.org/10.1038/s41564-026-02269-8